Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Incannex Healthcare Limited
  6. News
  7. Summary
    IHL   AU000000IHL8

INCANNEX HEALTHCARE LIMITED

(IHL)
  Report
Delayed Australian Stock Exchange  -  12:10:48 2023-01-27 am EST
0.1900 AUD    0.00%
01/27Public Announcement (asx : IHL) (NASDAQ: IXHL) - Form 6-K
PU
01/18Sector Update: Health Care Stocks Continue to Weaken in Late Trade
MT
01/18Sector Update: Health Care Stocks Sinking with Broader Markets Wednesday
MT
SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Incannex Healthcare Taps Eurofins Scientific for Manufacturing Medicated Chewables

11/24/2022 | 09:58pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
EUROFINS SCIENTIFIC SE 1.11% 65.68 Real-time Quote.-2.06%
INCANNEX HEALTHCARE LIMITED 0.00% 0.19 Delayed Quote.8.57%
All news about INCANNEX HEALTHCARE LIMITED
01/27Public Announcement (asx : IHL) (NASDAQ: IXHL) - Form 6-K
PU
01/18Sector Update: Health Care Stocks Continue to Weaken in Late Trade
MT
01/18Sector Update: Health Care Stocks Sinking with Broader Markets Wednesday
MT
01/18Incannex Healthcare Says Independent Data Review For Psilocybin Program's Phase 2 Trial..
MT
01/18Independent data review commences for Phase 2 trial of psilocybin-assisted psychotherap..
AQ
01/18Incannex Healthcare Begins Interim Analysis of Ongoing Anxiety Trial
MT
01/17Incannex Healthcare Limited Announces Independent Data Review Commences for PH 2 Trial ..
CI
2022Top Premarket Gainers
MT
2022Incannex Healthcare discusses A$13 million institutional placement
AQ
2022Incannex Healthcare discusses A$13 million institutional placement
EQ
More news
Financials
Sales 2023 - - -
Net income 2023 - - -
Net Debt 2023 - - -
P/E ratio 2023 -
Yield 2023 -
Capitalization 303 M 215 M 215 M
Capi. / Sales 2023 -
Capi. / Sales 2024 -
Nbr of Employees 3
Free-Float 83,8%
Chart INCANNEX HEALTHCARE LIMITED
Duration : Period :
Incannex Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INCANNEX HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers and Directors
Joel Latham CEO, Group MD & Executive Director
Madhukar Bhalla Chief Financial Officer & Secretary
Troy Valentine Independent Non-Executive Chairman
Mark Bleackley Chief Scientific Officer
Rosemarie Walsh Vice President-Clinical Operations